All tenders
75N93026C00012
TO DEVELOP A THERAPEUTIC SMALL MOLECULE VIRAL ENTRY INHIBITOR AS A MEDICAL COUNTERMEASURE FOR FILOVIRUS INFECTION.
Department of Health and Human Services · CA, United States
This contract has been awarded. Browse open opportunities
Time Left to Bid
Awarded
AwardedHealthcare & MedicalFederal
Basic information
- Reference number
- 75N93026C00012
- Issuing organization
- Department of Health and Human Services · Find award history →
- Government level
- Federal
- Solicitation type
- Healthcare & Medical
- Title
- TO DEVELOP A THERAPEUTIC SMALL MOLECULE VIRAL ENTRY INHIBITOR AS A MEDICAL COUNTERMEASURE FOR FILOVIRUS INFECTION.
- Source
- usaspending
- Source ID
- CONT_AWD_75N93026C00012_7529_-NONE-_-NONE-
Details
- Location
- CA, United States
Description
TO DEVELOP A THERAPEUTIC SMALL MOLECULE VIRAL ENTRY INHIBITOR AS A MEDICAL COUNTERMEASURE FOR FILOVIRUS INFECTION. Awarded to: ARISAN THERAPEUTICS INC Sub-agency: National Institutes of Health Contract type: DEFINITIVE CONTRACT
Dates
- Publication
- 2026/08/03 12:00:00 AM UTC
- Closing date
- 2027/06/30 12:00:00 AM UTC
Estimated value
$2.9M USD
Classification
Normalized category
Healthcare & Medical